Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lori Minasian

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Bioconjugate Chemistry|August 8, 2024
Bioconjugates for Cancer Prevention: Opportunities for ImpactErin Lavik, Lori Minasian
Cancer|January 23, 2020
New strategies in ovarian cancer treatmentJung-Min Lee, Lori Minasian, Elise C Kohn
Frontiers in Oncology|May 6, 2016
The End of the Hysterectomy Epidemic and Endometrial Cancer Incidence: What Are the Unintended Consequences of Declining Hysterectomy Rates?Sarah M Temkin, Lori Minasian, Anne-Michelle Noone
Clinical Obstetrics and Gynecology|September 29, 2017
Ovarian Cancer Prevention in High-risk WomenSarah M Temkin, Jennifer Bergstrom, Goli Samimi, et al.
The Oncologist|May 2, 2008
Intraperitoneal chemotherapy for women with epithelial ovarian cancerEdward L Trimble, Sharon Thompson, Michaele C Christian, et al.
American Journal of Obstetrics and Gynecology|April 10, 2018
Use of raloxifene and tamoxifen by breast cancer risk level in a Medicare-eligible cohortPaul F Pinsky, Eric Miller, Brandy Heckman-Stoddard, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|May 21, 2019
A Rare Opportunity: Examining the Experience of a New Institutional Review BoardLinda Parreco, Lisa Rooney, Sharon Hampp, et al.
Preventive Medicine|August 27, 2021
Adherence with protocol medication use and mortality from unrelated causes in a prevention trialPaul Pinsky, Phyllis Goodman, Howard Parnes, et al.
Medical Care Research and Review : MCRR|May 18, 2007
Determinants of implementation effectiveness: adapting a framework for complex innovationsChristian D Helfrich, Bryan J Weiner, Martha M McKinney, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 5, 2019
Breast Cancer Characteristics and Survival among Users versus Nonusers of RaloxifenePaul F Pinsky, Eric A Miller, Brandy M Heckman-Stoddard, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Bioconjugate Chemistry|August 8, 2024
Bioconjugates for Cancer Prevention: Opportunities for ImpactErin Lavik, Lori Minasian
Cancer|January 23, 2020
New strategies in ovarian cancer treatmentJung-Min Lee, Lori Minasian, Elise C Kohn
Frontiers in Oncology|May 6, 2016
The End of the Hysterectomy Epidemic and Endometrial Cancer Incidence: What Are the Unintended Consequences of Declining Hysterectomy Rates?Sarah M Temkin, Lori Minasian, Anne-Michelle Noone
Clinical Obstetrics and Gynecology|September 29, 2017
Ovarian Cancer Prevention in High-risk WomenSarah M Temkin, Jennifer Bergstrom, Goli Samimi, et al.
The Oncologist|May 2, 2008
Intraperitoneal chemotherapy for women with epithelial ovarian cancerEdward L Trimble, Sharon Thompson, Michaele C Christian, et al.
American Journal of Obstetrics and Gynecology|April 10, 2018
Use of raloxifene and tamoxifen by breast cancer risk level in a Medicare-eligible cohortPaul F Pinsky, Eric Miller, Brandy Heckman-Stoddard, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|May 21, 2019
A Rare Opportunity: Examining the Experience of a New Institutional Review BoardLinda Parreco, Lisa Rooney, Sharon Hampp, et al.
Preventive Medicine|August 27, 2021
Adherence with protocol medication use and mortality from unrelated causes in a prevention trialPaul Pinsky, Phyllis Goodman, Howard Parnes, et al.
Medical Care Research and Review : MCRR|May 18, 2007
Determinants of implementation effectiveness: adapting a framework for complex innovationsChristian D Helfrich, Bryan J Weiner, Martha M McKinney, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 5, 2019
Breast Cancer Characteristics and Survival among Users versus Nonusers of RaloxifenePaul F Pinsky, Eric A Miller, Brandy M Heckman-Stoddard, et al.
Pageof 8